C3 and COVID-19: The increased deposition of MBL, MASP-2, C3b, C4b, and C5b-9 on endothelial cells in COVID-19 patients is similar to the pathophysiology demonstrated in aHUS, which may serve to explain COVID-19’s potential triggering function of aHUS [11,12].